Increased intrarenal expression of sodium-dicarboxylate cotransporter-1 in nephrolithiasis patients with acidic urine pH

1. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011; 79:1178-85.10.1038/ki.2011.76Open DOISearch in Google Scholar

2. Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997; 4:537-40.10.1111/j.1442-2042.1997.tb00304.xOpen DOISearch in Google Scholar

3. Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011; 6:2069-75.10.2215/CJN.10651110Open DOISearch in Google Scholar

4. Zacchia M, Preisig P. Low urinary citrate: an overview. J nephrol. 2010; 23 Suppl 16:S49-56.Search in Google Scholar

5. Hamm LL, Hering-Smith KS. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am. 2002; 31:885-93.10.1016/S0889-8529(02)00031-2Open DOISearch in Google Scholar

6. Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991; 18:624-37.10.1016/S0272-6386(12)80602-0Open DOISearch in Google Scholar

7. Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20:371-7.Search in Google Scholar

8. Aruga S, Wehrli S, Kaissling B, Moe OW, Preisig PA, Pajor AM, et al. Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int. 2000; 58:206-15.10.1046/j.1523-1755.2000.00155.x10886565Open DOISearch in Google Scholar

9. Hamm LL. Renal handling of citrate. Kidney Int. 1990; 38:728-35.10.1038/ki.1990.2652232510Open DOISearch in Google Scholar

10. Pajor AM. Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney. Am J Physiol. 1996; 270:F642-8.10.1152/ajprenal.1996.270.4.F6428967342Search in Google Scholar

11. Pajor AM, Sun N. Functional differences between rabbit and human Na(+)-dicarboxylate cotransporters, NaDC-1 and hNaDC-1. Am J Physiol. 1996; 271: F1093-9.10.1152/ajprenal.1996.271.5.F10938946005Search in Google Scholar

12. Okamoto N, Aruga S, Matsuzaki S, Takahashi S, Matsushita K, Kitamura T. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol. 2007; 14:344-9.10.1111/j.1442-2042.2007.01554.x17470169Open DOISearch in Google Scholar

13. Youngjermchan P, Pumpaisanchai S, Ratchanon S, Pansin P, Tosukhowong P, Tungsanga K, et al. Hypocitraturia and hypokaliuria: major metabolic risk factors for kidney stone disease. Chula Med J. 2006; 50:605-21.Search in Google Scholar

14. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis. 2006; 48:546-54.10.1053/j.ajkd.2006.06.00816997050Open DOISearch in Google Scholar

15. Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res. 2005; 33:65-9.10.1007/s00240-004-0444-415565439Open DOISearch in Google Scholar

16. Aruga S, Pajor AM, Nakamura K, Liu L, Moe OW, Preisig PA, et al. OKP cells express the Na-dicarboxylate cotransporter NaDC-1. Am J Physiol Cell Physiol. 2004; 287:C64-72.10.1152/ajpcell.00061.200314973148Search in Google Scholar

17. Pajor AM. Citrate transport by the kidney and intestine. Semin Nephrol. 1999; 19:195-200.Search in Google Scholar

18. Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007; 35: 185-91.10.1007/s00240-007-0098-017541572Open DOISearch in Google Scholar